14 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... Microorganisms Causing Native ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Illness: • Antimicrobial ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... Susceptibilities, Negative ... or TEE unless clinical ... #candida #candidiasis
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... #Candidiasis #candida ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... evidence, and relative ... Tuberculosis #MDRTB #management ... #Treatment #antimicrobials ... #pharmacology #
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
POSITIVES - GRAM NEGATIVES ... metronidazole Antimicrobial ... (Use clinical data ... #antibiotics #management ... #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Tuberculosis #MDRTB #management ... #Treatment #antimicrobials ... #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Infection (Diffuse Pulmonary ... • Use until clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
as substantial clinical ... improvement and a negative ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology